Repository logo
 
Publication

Epidemiologia da Demência e da Doença de Alzheimer em Portugal: Estimativas da Prevalência e dos Encargos Financeiros com a Medicação

dc.contributor.authorSantana, Isabel
dc.contributor.authorFarinha, Filipa
dc.contributor.authorFreitas, Sandra
dc.contributor.authorRodrigues, Vitor
dc.contributor.authorCarvalho, Álvaro
dc.date.accessioned2015-10-08T14:25:52Z
dc.date.available2015-10-08T14:25:52Z
dc.date.issued2015
dc.description.abstractIntroduction: The incidence and prevalence of global dementia and Alzheimer’s disease (AD) increase with age, almost doubling every five years after the sixth decade of life. Demographic aging is a reality in Portugal, being expectable that the number of dementia cases also increases. Even so, dementia-epidemiological data in Portugal is scarce and cost-of-illness studies are almost inexistent. Our aims were to obtain up-to-date information about the prevalence of dementia/ Alzheimer’s disease in Portugal, to estimate the number of cases effectively diagnosed as Alzheimer’s disease and to determine illness-costs with specific dementia treatment. Material and Methods: The numbers of age-adjusted prevalence of dementia obtained for Occidental Europe (Alzheimer’s Disease International study), where applied to the resident population in Portugal (2013). Estimations related to diagnosis and treatment-costs were based in data provided by the Intercontinental Marketing Services Health (IMSH) – 2013. Results: The estimated number of Portuguese people with dementia among those aged ≥ 60 years, is 160287, representing 5.91% of this population-stratum. Knowing Alzheimer’s disease is responsible for 50-70% of all cases, we might conclude there are between 80144 and 112201 patients. According to IMSH-data, 76250 receive anti-dementia drugs and the costs of this kind of medication is 37 M€/year. Conclusions: As a consequence of the demographic aging, also the number of dementia cases increases. Aparentely, not all Alzheimer’s disease patients receive the recommended medication, suggesting this condition is still under-diagnosed. However, figures indicate a positive progression with an increment of treated cases and a reduction of medication-costs.pt_PT
dc.identifier.issn1646-0758
dc.identifier.urihttp://hdl.handle.net/10400.26/9884
dc.language.isoporpt_PT
dc.peerreviewedyespt_PT
dc.publisherOrdem dos Médicospt_PT
dc.relation.publisherversionhttp://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6025/4295pt_PT
dc.subjectDoença de Alzheimerpt_PT
dc.subjectCustospt_PT
dc.subjectEpidemiologiapt_PT
dc.subjectPortugalpt_PT
dc.titleEpidemiologia da Demência e da Doença de Alzheimer em Portugal: Estimativas da Prevalência e dos Encargos Financeiros com a Medicaçãopt_PT
dc.title.alternativeThe Epidemiology of Dementia and Alzheimer Disease in Portugal: Estimations of Prevalence and Treatment-Costspt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.conferencePlaceLisboapt_PT
oaire.citation.endPage188pt_PT
oaire.citation.issue2pt_PT
oaire.citation.startPage182pt_PT
oaire.citation.titleActa Médica Portuguesapt_PT
oaire.citation.volume28pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
6025-14401-1-PB.pdf
Size:
472.93 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.85 KB
Format:
Item-specific license agreed upon to submission
Description: